• Blog
  • Oral Cancer Treatment Market Analysis | 2022-2028

    Oral Cancer Treatment Market Analysis | 2022-2028

    Oral Cancer Treatment Market Analysis | 2022-2028
    Report code - SR2291 Delivery - 2 Weeks
    Oral Cancer Treatment Market Size, Share, Trend, Forecast, Competitive Analysis, and Growt See more...

    Market Insights

    The Oral Cancer Treatment Market was estimated at US$ 1.8 billion in 2021 and is expected to grow at a CAGR of 5.8% during 2022-2028 to reach US$ 3.80 billion in 2028.

    Wish to get a free sample? Register Here

    What is an oral cancer?

    Oral cancer is another type of deadly disease that has been diversified in terms of various types of oral cancers such as squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinoma, lymphomas, and others that have been proven to be deadly and dangerous in terms of population affected by them. Though oral cancers are non-communicable diseases, they impact a considerable section of the population worldwide.

    Market Dynamics

    The rising global prevalence of oral or mouth cancer is a primary factor driving market expansion. Rising investment in healthcare infrastructure development, rising consumption of tobacco products such as cigarettes, cigars, pipes, and chewing tobacco, and an increase in special designation from regulatory agencies are all factors driving market expansion. Another indirect variable that would generate profitable market growth potential is rising personal disposable income along with the rising frequency of papillomavirus infection.

    The oral cancer treatment market is one of the rapidly improving market structures, with better future results expected due to an increase in the number of cases of oral cancer surgeries, which leads to ongoing investments in the establishment and growth of the oral cancer treatment market size and share. Oral cancer accounts for 4% of all cancer cases and 2.2% of fatalities in the United States. Oral cancer accounts for 2% to 6% of all cancer cases in Western countries. Furthermore, in Asia-Pacific, men are more likely than women to develop oropharyngeal cancer. According to the National Cancer Institute, 60% of persons with oral cancer live for five years or longer, while 70% to 90% of people with Stage 1 or 2 cancer live for five years or longer.

    Increased consumption of tobacco products and alcoholic beverages, which have severe consequences and are regarded as the leading causes of oral cancer among young people worldwide, has been a major key driver that has boosted oral cancer treatment market share and established a favourable trend. Increased spending on healthcare infrastructure development, increased consumption of tobacco products such as cigarettes, cigars, pipes, and chewing tobacco, and an increase in special designation from regulatory agencies are all factors driving market expansion. Another indirect variable that would provide attractive market growth potential is an increase in personal disposable income combined with an increase in the prevalence of papillomavirus infection.

    Another major driver in the global oral cancer treatment market has been the increasing number of health awareness programmes and missions that have motivated people all over the world to improve their health stats and to be aware of the diseases that can be caused by the consumption of various products. Furthermore, advancements in healthcare facilities around the world have aided the oral cancer treatment industry.

    However, a lack of awareness regarding oral cancer in backward and impoverished areas would offer a significant barrier to market growth. Furthermore, the high expenditures connected with research and development capabilities, combined with a scarcity of trained individuals, will derail the market's growth rate. in addition to that, the risk of recurrence after treatment hinders the growth of the market. The overall growth in the oral cancer market has been rapid, but certain constraints are impeding the industry's growth, including huge sums of money to be invested initially in the establishment of oral cancer treatment companies, which limits the ability of various new players to enter the markets.

    Another major impediment to increasing the market share of oral cancer treatments is the risk associated with cancer treatment and the recurrence of cancer even after treatment, which remains one of the major drawbacks and makes the situation of the patients even worse because cancer can still return being more lethal even after the painful treatment processes and surgeries. Another major stumbling block that has recently been identified is the high cost of oral cancer treatment, which excludes most patients who do not have adequate financial resources and also affects the oral cancer treatment market share because it cannot cater to a diverse range of patients from various socioeconomic backgrounds.

    Oral Cancer Treatment Market Report Overview

    Market Size in 2028

    US$ 3.80 billion

    Market Size in 2021

    US$ 1.8 billion

    Market Growth (2022-2028)

    5.8% CAGR

    Base Year of Study

    2021

    Trend Period

    2016-2020

    Forecast Period

    2022-2028

     

    Several investments/guidelines in the industry have been directed in recent years, which would boost the overall market. Some of them are:

    • According to the Oral Cancer Foundation, 53000 new cases of oral cancer are diagnosed each year, with approximately 10000 people dying as a result of the fatal disease. The most common symptoms of oral cancer are normal but clinical, such as a sore throat, gum discomfort, swelling around the lips, and enlargement of the entire face. These symptoms are a strong indication of oral cancer, which if not treated promptly and appropriately can spread to the rest of the body. However, developments in technology and improved healthcare facilities have contributed to an improvement in the oral cancer treatment industry.

    Segments Analysis

    By Type

    The oral cancer treatment market is segmented into oral squamous cell carcinoma, oral verrucous carcinoma, mucoepidermoid carcinoma, and oral cavity lymphomas.

    By Therapy Type

    The oral cancer treatment market is segmented into chemotherapy, radiation therapy, and biological therapy.

    By Treatment Type

    The oral cancer treatment market is segmented into medication and surgery. 

    By Route of Administration Type

    The oral cancer treatment market is segmented into oral, injectable, and others. 

    By End-User Type

    The oral cancer treatment market is segmented into hospitals, home care, specialty clinics, and others.

    Regional Analysis

    The oral cancer treatment market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Because of the increased affordability of medications and the increase in incidences of mouth cancer, North America dominates the oral cancer treatment industry. For the forecast period, Asia-Pacific is expected to have the greatest growth rate and CAGR. This is due to rising healthcare infrastructure development costs and rising cigarette consumption.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    The following are the major players in the oral cancer treatment market:

    • Bristol-Myers Squibb Company
    • Qilu Pharmaceutical Co., Ltd
    • Teva Pharmaceutical Industries Ltd.
    • Eli Lilly and Company
    • F Hoffmann-La Roche Ltd
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.

    Manufacturers have been concentrating on creating top-notch products to sustain their market position.

    For instance:

    • Takeda Pharmaceutical Firm bought Gammadelta Therapeutics Limited in October 2021, a company focused on exploiting unique features of cells for immunotherapy. This would allow the major firm to profit from all of the acquired company's intellectual property.
    • Roche will release a new profiling kit in October 2021 that will allow cancer researchers to easily assess tumours without needing to send tissue samples to centralised laboratories. This would be a substantial boost to the market for medical cancer research.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Oral Cancer Treatment Market 

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com

    Frequently Asked Questions (FAQs)

    The oral cancer treatment market is estimated to grow at a healthy CAGR of 5.8% over the next five years.

    The oral cancer treatment market is likely to reach US$ 3.80 billion in 2028.

    The rising global prevalence of oral or mouth cancer is a primary factor driving market expansion. Rising investment on healthcare infrastructure development, rising consumption of tobacco products such as cigarettes, cigars, pipes, and chewing tobacco, and an increase in special designation from regulatory agencies are all factors driving market expansion.

    Because of the increased affordability of medications and the increase in incidences of mouth cancer, North America dominates the oral cancer treatment industry.

    The major players in the oral cancer treatment market are Bristol-Myers Squibb Company, Qilu Pharmaceutical Co., Ltd, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, F Hoffmann-La Roche Ltd, Merck & Co., Inc., Novartis AG, and Pfizer Inc.

    The market is studied from 2016-2028.